Physician profile
Taylor Kinder
NPI 1518696020
$4,326.10
in general payments reported to CMS, 2019-2025
25 companies · $1,039 in 2025
The $1,039 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $420 · 2023: $1,720 · 2024: $1,148 · 2025: $1,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,886 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,885.99 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $708.34 | 2022-2025 | |
| Novo Nordisk INC | $612.02 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $469.22 | 2023-2024 | Brilinta, Lokelma, Farxiga |
| Novartis Pharmaceuticals Corporation | $353.93 | 2022-2025 | |
| Amgen INC. | $349.57 | 2023-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $337.40 | 2022-2025 | Verquvo, Capvaxive |
| Esperion Therapeutics, INC. | $259.43 | 2022-2025 | Nexletol |
| Pfizer INC. | $236.75 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $220.50 | 2022-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.17 | 2022-2024 | Jardiance |
| Baxter Healthcare | $132.19 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Boston Scientific Corporation | $68.73 | 2025 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $67.03 | 2022-2024 | Onpattro |
| Atricure, INC. | $58.91 | 2024-2025 | Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $56.85 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $48.93 | 2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $43.61 | 2022-2023 | Xarelto |
| Heartflow, INC. | $37.55 | 2025 | |
| Daiichi Sankyo INC. | $29.86 | 2023-2024 | Injectafer |
| Actelion Pharmaceuticals US, INC. | $25.45 | 2024 | Uptravi, Opsumit |
| Shockwave Medical, INC | $17.62 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lexicon Pharmaceuticals, INC. | $16.92 | 2023 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $14.00 | 2025 | Eliquis |
| Azurity Pharmaceuticals, INC. | $13.21 | 2024 | Edarbyclor |
| Sanofi-Aventis U.S. LLC | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Kinder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.